Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Engaging openly with that process including reporting unexpected changes in weight or any new symptoms contributes to the broader evidence base and ensures your own care remains appropriately tailored
Journal of Biological Chemistry, 287(7), 4552-4561
Versatile usage : Ideal for reconstituting peptides, hormones, and other medications for injectable use
Combination with Metformin or Metformin with Sulfonylurea In a 30-week, open-label trial (NCT02128932), 1089 patients with type 2 diabetes mellitus were randomized to semaglutide 0.5 mg once weekly, semaglutide 1 mg once weekly, or insulin glargine once daily on a background of metformin (48%) or metformin and sulfonylurea (51%)
Long-term safety data, cardiovascular outcomes, and real-world effectiveness data are not yet available
2013;8:e57998
